Roisin O'Cearbhaill

29PUBLICATIONS
203CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 01, 2026
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.

|Aug 11, 2026
Seasonal variation and risk of paclitaxel-induced hypersensitivity reactions: A retrospective cohort study.

|Jul 27, 2026
Outpatient rapid drug desensitisation for chemotherapy and biologic agents: high success rates in a large single-centre cohort study.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Mar 05, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

Ramez N Eskander, Michael W Sill, Lindsey Beffa

|Jan 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong

Pageof 5

Frequent Collaborators

5 joint publications

Britta Weigelt

5 joint publications

William P Tew

5 joint publications

Qin Zhou

5 joint publications

Alexia Iasonos